about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesPositive and negative functions of B lymphocytes in tumorsExploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndromePathophysiology of chronic rhinosinusitis, pharmaceutical therapy optionsDefects in Germinal Center Selection in SLEThe rationale for BAFF inhibition in systemic lupus erythematosusRegulation of Aicda expression and AID activityUnderstanding the role of B cells in atherosclerosis: potential clinical implicationsEffect of TACI signaling on humoral immunity and autoimmune diseasesMolecular pathogenesis of neuromyelitis opticaNon-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple JuncturesFusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivoA1/Bfl-1 in leukocyte development and cell deathMechanisms of autoantibody production in systemic lupus erythematosusB cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleenAberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survivalTRAF3 deficiency promotes metabolic reprogramming in B cellsMurine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity.B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupusLong-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.Dose-escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma.BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.Role of the translocation partner in protection against AID-dependent chromosomal translocationsB cells in rheumatoid arthritis: from pathogenic players to disease biomarkers.Modulation of Mycobacterium tuberculosis-specific humoral immune responses is associated with Strongyloides stercoralis co-infectionB lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.Mechanisms of Autoantibody-Induced Pathology.Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment.B cells and humoral immunity in atherosclerosisThe strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF).Roles of the NF-kappaB pathway in lymphocyte development and function.Elevated serum levels of visfatin in patients with henoch-schönlein purpura.Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival.Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemiasA novel VHH antibody targeting the B cell-activating factor for B-cell lymphoma.Altered B cell signalling in autoimmunity.Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity.
P2860
Q24624348-98D9C120-B071-4361-BFE5-E4B6D357CC48Q26743398-CFF55FF8-9AE0-4F48-80AA-180E12848B86Q26770648-A8C71E6C-7618-4753-89D9-22C65B4E49BBQ26771860-5FBE3DBC-D878-4B6C-853D-8DF9B5457A53Q26796041-A4063A2F-BF75-4B18-8180-BF3F53B89F39Q26827373-D38DDFFB-0A4D-43F7-9491-13BF6C2AC8E0Q26853622-2C462669-4EC2-4E5D-AD05-9F318F77A72CQ26991813-00C3BE96-A891-43AC-B328-19545F198254Q26995571-54FA41BD-8669-4805-9FDE-70DA72429BFAQ27021535-C3D171A3-A327-4AAA-8D9F-F843747FC5D8Q27024640-07681909-920C-4382-BCC0-53934F9A78E2Q27314650-8D6FE10E-C6F4-46A9-8466-76B8E7D2993CQ27691571-D1B99AD4-F183-4BA6-BD9D-8EF5D2A3DBFAQ28082507-B6DB0700-0614-4582-9787-9109A20B159FQ28256100-024165C3-8A3F-465D-922A-E540331D4749Q28743862-570A9409-7439-40F1-B2F1-2E2D513EC1A0Q28820861-88B663ED-18A2-4209-8E06-2ACFA25CBC3AQ30415556-7872838E-5203-4C0A-977B-DA7AC8EEC5ECQ30426692-E63EAC81-8DFB-48AE-A5D2-45873948C42BQ33412584-D7207C0A-6ACB-4AE1-8B52-7C4CA91B4B42Q33418352-FC67B63D-E4AA-4C03-A316-B18336450F04Q33429051-C570B8A7-DB9B-448A-B156-44FCBADADA23Q33433447-EFB43280-2F67-4D0C-8E37-406EEA8A9A6AQ33573335-31416377-1CC9-4F04-AA6B-39009740969FQ33591714-4029E656-92F1-4BDE-A5E3-A665C27964B0Q33616360-9D1AB2C7-D9EA-412D-B2FC-F93731021418Q33664416-25C819E8-D40B-4CFF-81C8-76E2D2A8843AQ33704093-863CCC47-5572-4283-9B01-5B5325D12E20Q33740580-9215671A-B873-407C-90B3-F0A13AE469BFQ33760703-01D2F019-0265-4285-9936-AF36EB606C3DQ33789638-0309A485-D7B8-4566-9AE8-3C09A6AFE670Q33792424-3A864991-A877-4D94-833A-BB95E9C1447EQ33800318-DF61CC49-A303-4C36-92F8-DB6321DC78C0Q33801961-4A03F284-A01E-42F0-9B12-E3F68BD6F525Q33821167-0CD7BCA7-23CD-47FD-A2D6-5AE493C29A38Q33891669-19689851-EDB2-4B06-B7AA-E42BD9AC7891Q33891940-2863E914-53A4-4E3C-B666-B8B065475D09Q33907508-0917B15F-7CC7-41E2-B221-24CD4BA57160Q33924642-52842022-E4D2-4E54-ABDC-3E15EE891E94Q33934522-BAE6B51F-7412-45ED-9D31-6FFC6490ED2E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Cracking the BAFF code.
@en
Cracking the BAFF code.
@nl
type
label
Cracking the BAFF code.
@en
Cracking the BAFF code.
@nl
prefLabel
Cracking the BAFF code.
@en
Cracking the BAFF code.
@nl
P2860
P356
P1476
Cracking the BAFF code
@en
P2093
Fabienne Mackay
Pascal Schneider
P2860
P304
P356
10.1038/NRI2572
P407
P577
2009-07-01T00:00:00Z